For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating-and possibly even ...

The cell nucleus goes a long way during an immune response, both literally and figuratively. New research published in Science Immunology shows that in some white blood cells, this genetic storage ...

For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating—and possibly even ...

Learn the truth behind common lung cancer myths, including risk factors, treatment options, and the importance of early screening for better prevention and management.

A groundbreaking injectable drug, lenacapavir, offers renewed hope in the fight against HIV. Set to be available in 2027 in over 100 low and middle-income countries at an affordable price of $40 per ...

To reflect this reality, the Gladstone Institute of Virology has taken on a new name: the Gladstone Infectious Disease ...

The approval of mRNA vaccines couldn’t have come too soon. Not only did the two original COVID mRNA vaccines save an ...

Replacing immune cells called microglia holds promise for addressing brain conditions such as Alzheimer’s disease.

A total of 10 individuals with HIV have been cured to date. Most of these patients have remained anonymous, but three have ...

Lenacapavir, a Long-acting injectable drug used to prevent HIV, will be made available for $40 a year in over 120 low- and middle-income countries, under a new agreement announced this week between ...